Cargando…

A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 – 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study

BACKGROUND: Pneumonia is the leading cause of child mortality under five years of age worldwide. For pneumonia with chest indrawing in children aged 3–59 months, injectable penicillin and hospitalization was the recommended treatment. This increased the health care cost and exposure to nosocomial in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Archana B., Bang, Akash, Singh, Meenu, Dhande, Leena, Chelliah, Luke Ravi, Malik, Ashraf, Khadse, Sandhya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650851/ https://www.ncbi.nlm.nih.gov/pubmed/26577943 http://dx.doi.org/10.1186/s12887-015-0510-9

Ejemplares similares

Treatment of Severe Community-Acquired Pneumonia with Oral Amoxicillin in Under-Five Children in Developing Country: A Systematic Review
por: Das, Rashmi Ranjan, et al.
Publicado: (2013)

A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia
por: Danneels, Pierre, et al.
Publicado: (2020)

Oral Amoxicillin Versus Benzyl Penicillin for Severe Pneumonia Among Kenyan Children: A Pragmatic Randomized Controlled Noninferiority Trial
por: Agweyu, Ambrose, et al.
Publicado: (2015)

Crowdsourcing the identification of organisms: A case-study of iSpot
por: Silvertown, Jonathan, et al.
Publicado: (2015)

Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit
por: Habayeb, H., et al.
Publicado: (2015)

Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy
por: Veeraraghavan, Balaji, et al.
Publicado: (2020)

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial
por: Shahrin, Lubaba, et al.
Publicado: (2020)

Cold Chain-Free Storable Hydrogel for Infant-Friendly Oral Delivery of Amoxicillin for the Treatment of Pneumococcal Pneumonia
por: Xu, Keming, et al.
Publicado: (2017)

Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae
por: Plouffe, Joseph F., et al.
Publicado: (2004)

Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2–59 Months with pneumonia, Kenya: A cluster randomized controlled trial
por: Angwa, Linet M., et al.
Publicado: (2020)

Efficacy of high doses of oral penicillin versus amoxicillin in the treatment of adults with non-severe pneumonia attended in the community: study protocol for a randomised controlled trial
por: Llor, Carl, et al.
Publicado: (2013)

iSPOT: A Web Tool for the Analysis and Recognition of Protein Domain Specificity
por: Brannetti, Barbara, et al.
Publicado: (2001)

Randomized trial of amoxicillin vs. placebo for pneumonia in Pakistan: A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
por: Jehan, Fyezah, et al.
Publicado: (2020)

Compartmentalized cross-linked enzyme nano aggregates (c-CLEnAs) toward pharmaceutical transformations
por: de Martino, M. Teresa, et al.
Publicado: (2021)

Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial
por: Ahmed, Sheraz, et al.
Publicado: (2022)

Compartmentalized cross-linked enzymatic nano-aggregates (c-CLEnA) for efficient in-flow biocatalysis
por: De Martino, M. Teresa, et al.
Publicado: (2020)

Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children
por: Hanning, Sara M, et al.
Publicado: (2020)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

Amoxicillin-Clavulanic Acid Empirical Oral Therapy for the Management of Children with Acute Haematogenous Osteomyelitis
por: Serrano, Elena, et al.
Publicado: (2020)

Continuous Professional Oral Health Care Intervention Improves Severe Aspiration Pneumonia
por: Nawata, Wakako, et al.
Publicado: (2019)

Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for Its Effectiveness
por: Gupta, Tanvi, et al.
Publicado: (2020)

Characteristics and results of a series of 59 patients with severe pneumonia due to COVID-19 admitted in the ICU()
por: Serrano-Martínez, J.L., et al.
Publicado: (2020)

Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report
por: Yoon, Byung Woo, et al.
Publicado: (2017)

Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study
por: Rae, Nikolas, et al.
Publicado: (2017)

Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
por: Zhu, Yonglin, et al.
Publicado: (2023)

Choosing the right combination therapy in severe community-acquired pneumonia
por: Waterer, Grant W, et al.
Publicado: (2006)

Targeting mesenchymal stem cell therapy for severe pneumonia patients
por: Lam, Guy, et al.
Publicado: (2021)

Clinical Effectiveness of Co-trimoxazole vs. Amoxicillin in the Treatment of Non-Severe Pneumonia in Children in India: A Randomized Controlled Trial
por: Rajesh, Shimoga Mahabala, et al.
Publicado: (2013)

Intravenous Amoxicillin Plus Intravenous Gentamicin for Children with Severe Pneumonia in Bangladesh: An Open-Label, Randomized, Non-Inferiority Controlled Trial
por: Shahrin, Lubaba, et al.
Publicado: (2021)

Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018)

Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers
por: Pathak, Priyanka, et al.
Publicado: (2017)

Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice
por: Yang, Zhangsheng, et al.
Publicado: (2014)

Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report
por: Braund, Taylor A., et al.
Publicado: (2021)

A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone
por: Hirai, Jun, et al.
Publicado: (2023)

A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
por: Jehan, Fyezah, et al.
Publicado: (2016)

Effects of steroid therapies to severe streptococcal pneumoniae that required mechanical ventilation
por: Nagura, T, et al.
Publicado: (2013)

Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
por: Gokhale, Nikhil S, et al.
Publicado: (2012)

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol
por: Williams, Leanne M, et al.
Publicado: (2011)

Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bbe773184g4duo0ksssr5rhuco